AzurRx BioPharma - Home

NASDAQ: AZRX

SEARCH

SIGN UP

Menu

Investor Relations

AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. 

Stock Quote - AzurRx (NASDAQ: AZRX)

*Delayed quote courtesy of Google.

Stock Chart

sdf

sdf

sdf

sdf

Recent Press Releases

Date Title
15 Apr, 2021 AzurRx BioPharma CEO Issues Letter to Shareholders
13 Apr, 2021 AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
06 Apr, 2021 AzurRx BioPharma Initiates Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections